Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
0.157
-0.008 (-4.96%)
At close: Jun 26, 2026, 4:00 PM EDT
0.163
+0.006 (3.50%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Gossamer Bio Stock Forecast
GOSS's stock price has decreased by -88.46% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 4.13, with a low estimate of 0.28 and a high estimate of 15. The average target predicts an increase of 2,530.57% from the current stock price of 0.16.
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 3 | 2 | 2 | 1 | 1 |
| Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 4 | 5 | 5 | 4 | 4 |
| Sell | 0 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $5 → $2 | Buy | Reiterates | $5 → $2 | +1,173.89% | Jun 25, 2026 |
Unknown Analyst Guggenheim No rating | Guggenheim | Hold Maintains n/a | Hold | Maintains | n/a | n/a | May 19, 2026 |
| Wedbush | Wedbush | Hold Maintains $1 | Hold | Maintains | $1 | +536.94% | May 19, 2026 |
| Barclays | Barclays | Sell Maintains $0.3 → $0.28 | Sell | Maintains | $0.3 → $0.28 | +78.34% | May 19, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Downgrades n/a | Hold | Downgrades | n/a | n/a | Mar 20, 2026 |
Financial Forecast
Revenue This Year
36.44M
from 48.47M
Decreased by -24.83%
Revenue Next Year
53.00M
from 36.44M
Increased by 45.45%
EPS This Year
-0.46
from -0.75
EPS Next Year
-0.09
from -0.46
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 46.6M | 112.2M | |
| Avg | 36.4M | 53.0M | |
| Low | 22.0M | 19.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -3.9% | 208.1% | |
| Avg | -24.8% | 45.4% | |
| Low | -54.6% | -45.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -0.46 | -0.09 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.